INTRODUCTION AND OBJECTIVES: Through Michelangelo's life and artwork we gain glimpses of the Italian artist's condition or recurrent kidney stones. Our aim was to search through literature to gain a better understanding of his symptoms and how he was treated for urolithiasis.
METHODS: A literature search was performed using PubMed and Google on Michelangelo Buonarroti and kidney stones. RESULTS: Michelangelo Buonarroti (1475 -1564 was presumed to suffer from chronic illness throughout life. He had a history of recurrent kidney stones as well as gout later in life. In 1999, Eknoyan claimed that Michelangelo's medical condition influenced his artwork. Eknoyan pointed out the painting, God Separating Earth from Waters, was drawn in the shape of a "bisected right kidney". Perhaps it is the artwork which stimulates further interest in Michelangelo's medical history. According to some authors, Michelangelo was diagnosed with kidney stones at age 75 in 1549 and was treated by Realdo Colombo. However, there is mention of symptoms and kidney problems prior to 1549. In The Life of Michelangelo, Condivi mentions "gravel in his urine" which may have preceded kidney stones. A Week in the Life of Michelangelo relates events from 1518-1526 where the artist kept records of the food he ate during the day as he was recommended to eat light meals to prevent stones. Most detailed accounts of Michelangelo's condition come from letters written to his nephew. In March 1549, he complains of difficulties with urination, fever, and pain which keeps him up at night. A few days later, in another letter he mentions being told to drink "a certain kind of water" which leads to passing of his stones along with "thick white matter". He continues to mention this "spring water from Vitterbo" as his treatment regimen and reports feeling better. While acknowledging the treatment, Michelangelo continues to pray and thank God in each of his letters which give us a glimpse of the importance of faith in his illness. Despite treatment, Michelangelo's health worsened and he was diagnosed with gout in 1555. The development of gout raises suspicion that he was suffering from urate stones. This could be due to a congenital medical illness or as Wolf suggested in 2005 it could be acquired from injury to his kidneys due to lead exposure from lead-based paints and wine stored in lead containers.
CONCLUSIONS: While the literature is inconclusive on the cause of Michelangelo's kidney stones, it appears that compounds found in the paint he used contributed to his health conditions, which later manifested in his artwork in the form of God emerging from a bisected kidney.
Source of Funding: none

FRII-02 HOW A UROLOGY CAREER ENDING HAND INJURY, PRODUCED A PIONEER OF URORADIOLOGY
Steven Brandes, Stephanie Thompson*, Robert Goldfarb, New York, NY INTRODUCTION AND OBJECTIVES: Dr. Howard Pollack retired as a well-known pioneer of uroradiology. He originally trained as a Urologist, but a disabling accident forced him to make a career change to Radiology. Dr. Pollack capitalized on the career change and helped found the specialty of GU radiology in the USA.
METHODS: Internet and historical archive review, as well as personal interviews with former residents and faculty RESULTS: A lifelong Philadelphian, Pollack graduated from Temple University for college and medical school, and then Episcopal Hospital, for urology residency. He initially worked as a military urologist, as Chief of Urology at the 1,100th U.S. Air Force Hospital and advisor to the Surgeon General 0 s office. On return to civilian life, Pollack had a prosaic career as a community urologist. In a freak accident at home, a glass injury severely injured his hands ,disabling him and ending his urologic career. Instead of surrendering to tragedy, at middle age he changed careers and retrained as a Radiologist. His true calling was radiology. He quickly became an academic specialist, by applying his urologic skills to radiology. First, as chairman and professor of radiology at Episcopal Hospital and then as founder of the division of uroradiology at the University of Pennsylvania in 1977. He codified the specialty by establishing the Uroradiology Club in 1966, The Society of Uroradiology in 1974 and The Journal of Urologic Radiology in 1979. His textbook, Clinical Urography has been the bible of uroradiology. He also helped invent the endorectal coil for prostate imaging, sonographic classification of renal masses, and developed and refined interventional procedures (six patented inventions). Dr. Pollack was also a renaissance man; an art and history buff, passionate detective novel reader, and accomplished jazz pianist, and life-long baseball fanatic and sports trivia master. He published several sports articles and was more proud of them then any academic manuscript. On retirement, he worked on a definitive guide to every sports museum and hall of fame in the USA. Ironically, he died of metastatic renal cell cancer.
CONCLUSIONS: Dr. Pollack 0 s life epitomized the saying 00 I asked for health, that I may do great things. I was given infirmity, that I might do better things. 00
Source of Funding: none
FRII-03
MAX WILMS: A TRIPHASIC HISTORY OF THE MAN, HIS EPONYMOUS TUMOR, AND ITS EVOLVING TREATMENT Kristina Suson*, Yegappan Lakshmanan, Janae Preece, Detroit, MI INTRODUCTION AND OBJECTIVES: Nephroblastoma has been described for over a century. We explored the man behind the eponym, advances in tumor biology, and its how its treatment has evolved since early descriptions.
METHODS: Literature review of Wilms and nephroblastoma. RESULTS: The Man: Born in 1867, Carolus Maximilianus Wilhemus Wilms initially pursued pathology but later secured a position with the surgeon Trendelenburg. During this time, published a three-part monograph, the first of which described mixed renal tumors. He pioneered new approaches to prostatectomy, though his interests extended far beyond urology. During his chief surgeon appointment to a World War I army corps, he became septic after performing a tracheotomy on a prisoner of war with diptheria, dying in 1918. The Tumor: Despite the eponym, Wilms tumor was described before his monograph. Microscopically confirmed as cancer in the 1850s, the mixed histology was not described until 1872. Wilms explored it further, identifying connective tissue, smooth and striated muscle, and epithelium, and proposed an embryologic origin in 1899; he was granted the eponym in 1900. Later pathologists identified traits, such as anaplasia, that impact outcomes and fine-tuned the triphasic elements described by Wilms into blastemal, epithelial and stromal components. Its association with multiple syndromes and occasional familial tumors primed it for genetic insights. Its Treatment: Jessop performed the first successful nephrectomy for nephroblastoma in 1877. Although the boy died 9 months later, he was one of the few early patients to survive nephrectomy for Wilms tumor; there was a debate among the surgical community as to whether surgery was ever appropriate because of the high mortality rate. Survival remained Vol. 197, No. 4S, Supplement, Monday, May 15, 2017 THE JOURNAL OF UROLOGY â e1067 abysmal well into the 20th century. Operative mortality decreased after 1932, but <25% remained alive for 2 years. The cure rate jumped to 47% in the 1940s, an improvement attributed to early vessel ligation and post-operative radiation. Survival dramatically increased again with the advent of chemotherapy for Wilms, first reported in 1960. In America (1969) and Europe (1971), multi-center research groups formed to elucidate the best treatments. The groups diverged on the timing of surgery and chemotherapy. Now in an era with improved survival, treatment goals include minimizing morbidity and following long term sequelae. CONCLUSIONS: Max Wilms, a man of diverse interests who died a hero, happened upon a biologically fascinating tumor. Its treatment, well-described for over a century, continues to evolve as we identify ways of maximizing survival with the least morbidity. RESULTS: The name J. Bentley Squier is not eponymous with any signs, symptoms, procedures or technique. Perhaps his most unique attribute was his short stature and a partially amputated thumb. Squier believed in surgical expediency and efficiency, best demonstrated by his suprapubic prostatectomy (which he championed over perineal prostatectomy); often completing the surgery 10 minutes; 12 minutes if with bladder stones.His small hands and partially amputated thumb were uniquely suited to a narrow pelvis and to core out the adenoma. He was quite the showman, awing audiences by emerging from the pelvis with the entire adenoma sitting atop his thumb like an apple on a stick. To create the world's first academic medical center, Squier moved his Urological clinic from Madison Avenue to a new 70 bed unit on the 10th floor of the new hospital. To do so, Squier raised $400,000 from his many devoted and wealthy patients. Squier was the Urologists to the stars; like world heavy weight boxing champ Gene Turney, and NY Times publishers Ochs and Sulzberger. The Clinic had its own operating and cystoscopy rooms, pathology and radiology departments, and library. In 1929, he established a 30-bed pediatric service in Babies Hospital. In 1935 he became Chair of Columbia 0 s first Urology Department. He was already an academic giant; as one of the founding fathers, President, Governor and Regent of the American College of Surgeons and President of The American Urological Society. Just like today's changing medical landscape, the 1930's were tough economic timesso the clinic targeted well-healed private patients by creating more private rooms, a $4 a day 00 pay ward 00 , and reducing charity beds . Increasing 00 fee for service 00 payers kept the Clinic solvent. Squier was succeeded as Chair in 1939, leaving behind a world-renowned and profitable Urology Department.
Source of Funding: None
CONCLUSIONS: The world of urology surrounding Squier resembles many challenges faced today: hospital mergers and acquisitions and a changing medical and economic landscape. Squier was a Urologic giant.
FRII-05
TOBIAS GOODMAN AND THE NEW ENGLAND ORIGIN OF URETEROSCOPY.
Joseph Yared*, Vernon Pais, Lebanon, NH INTRODUCTION AND OBJECTIVES: Ureteroscopy is one of the most commonly performed procedures in current urologic practice, although rigid ureteroscopy was unheard of until the very recent past. Its origins has direct New England ties. Although the first documented "ureteroscopy" is attributed to Hugh Hampton Young who performed inadvertent endoscopy of the ureter in a 2 month old child with posterior urethral valves, this 1929 report was essentially relegated to anecdote that lacked any practical application.50 years later, in a small New England town, diagnostic and therapeutic ureteroscopy were born with the first planned rigid ureteroscopy and the introduction of ureteroscopic-guided intervention.
METHODS: A comprehensive search of Medline was undertaken to assess all published articles describing ureteroscopy prior to 1980. References of identified papers were also reviewed to identify the earliest published accounts of rigid ureteroscopy. Upon identifying the initial reported ureteroscopy, the author was interviewed to better understand the context surrounding the inception of ureteroscopy.
RESULTS: The first report of planned rigid ureteroscopy was in 1977. The procedure was performed by Dr. Tobias M. Goodman at Westerly Hospital. Dr. Goodman attended Browne and Nichols school in Cambridge, MA, then matriculated to Harvard College where he was an accomplished scholar in Classic Languages. After graduating from residency at Boston Medical Center, he started solo practice in Westerly, RI. At the time, blind stone-basketing was standard practice, but he recounts unease with the imprecise nature of blind manipulation. Thirty years prior to the AUA recommendation against blind-basketing, he proposed to several patients an improved, directly visualized approach to management of ureteral pathology. With a reputation as a physician who "knew how to stay out of trouble," his patients eagerly agreed. Using a pediatric cystoscope with a standard bridge and an 11Fr sheath, he accessed, visualized and fulgurated a distal ureteral tumor. He developed techniques for diagnostic ureteroscopy and stone extraction, publishing the first series of rigid ureteroscopy in 1977. He subsequently developed patents for a ureteroscope, a 3-way endoscopic valve and Uroshiol for treatment of bladder cancer. Since retirement, he has authored 2 non-medical books: Out of the Attic and Ancient purple. He still resides in Westerly, RI where he is a guest columnist for the Westerly Sun.
CONCLUSIONS: Dr Tobias Goodman is a urologic pioneer who serves as an example of the creative thinking that has allowed the dramatic progress we continue to enjoy. . 197, No. 4S, Supplement, Monday, May 15, 2017 
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